Safety and effectiveness of capmatinib in patients with unresectable advanced/recurrent non-small cell lung cancer with METex14 skipping alterations: a post-marketing surveillance in Japan

International Journal of Lung Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles